中药与天然药干预三阴性乳腺癌的信号通路与靶点综述
该综述检索PubMed、Web of Science和CNKI 2010年1月至2020年6月文献,汇总中药与天然药(含提取物、活性成分和复方)干预三阴性乳腺癌的经典信号通路与潜在靶点,发现其通过PI3K/AKT/mTOR、MAPK和Wnt/β-catenin等通路调节相关基因与蛋白表达,抑制肿瘤细胞生长、增殖、迁移、侵袭和转移。
要点
- 中药与天然药经PI3K/AKT/mTOR、MAPK、Wnt/β-catenin等通路抑制TNBC细胞生长、增殖、迁移、侵袭和转移。
- 中药与天然药具有多靶点、副作用小的特点,可能作为长期补充替代疗法。
- 其疗效、安全性和作用机制仍需更深入的实验研究验证。
核心结论
- 中药与天然药在多个水平和多条通路上抑制肿瘤,为三阴性乳腺癌新药开发提供合理证据。
- 中药与天然药要广泛灵活用于临床,其疗效、安全性和作用机制仍需更深入的实验研究。
研究设计与样本
- 综述检索PubMed、Web of Science和CNKI数据库2010年1月至2020年6月的文献。
- 检索词包括「Triple negative breast cancer」或「triple negative breast carcinoma」、「TNBC」以及「traditional Chinese medicine」或「Chinese herbal medicine」、「medicinal plant」、「natural plant」、「herb」。
- 纳入文献涉及的中药与天然药包括提取物、活性成分和复方。
主要发现
- 植物药和中药复方通过PI3K/AKT/mTOR、MAPK和Wnt/β-catenin等通路调节相关基因与蛋白表达。
- 上述调节作用可抑制三阴性乳腺癌细胞的生长、增殖、迁移、侵袭和转移。
- 中药与天然药对肿瘤的抑制作用体现在多个水平和多条通路上。
临床怎么用
- 中药与天然药具有多靶点、副作用小的特点,可考虑作为三阴性乳腺癌的长期补充替代疗法。
- 临床应用需关注其疗效、安全性和作用机制,尚需更深入的实验研究支持。
局限性
- 中药与天然药要广泛灵活用于临床,其疗效、安全性和作用机制仍需更深入的实验研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Triple-negative breast cancer (TNBC) has a poorer prognosis than other subtypes due to its strong invasion and higher risk of distant metastasis. Traditional Chinese medicine (TCM) and natural medicine have the unique advantages of multitargets and small side-effects and may be used as long-term complementary and alternative therapies. AIM OF THE REVIEW: The present article summarizes the classical signaling pathways and potential targets by the action of TCM and natural medicine (including extracts, active constituents and formulas) on TNBC and provides evidence for its clinical efficacy. METHODS: The literature information was acquired from the scientific databases PubMed, Web of Science and CNKI from January 2010 to June 2020, and it was designed to elucidate the internal mechanism and role of TCM and natural medicine in the treatment of TNBC. The search key words included "Triple negative breast cancer" or "triple negative breast carcinoma", "TNBC" and "traditional Chinese medicine" or "Chinese herbal medicine", "medicinal plant", "natural plant", and "herb". RESULTS: We described the antitumor activity of TCM and natural medicine in TNBC based on different signaling pathways. Plant medicine and herbal formulas regulated the related gene and protein expression via pathways such as PI3K/AKT/mTOR, MAPK and Wnt/β-catenin, which inhibit the growth, proliferation, migration, invasion and metastasis of TNBC cells. CONCLUSION: The inhibitory effect of TCM and natural medicine on tumors was reflected in multiple levels and multiple pathways, providing reasonable evidence for new drug development. To make TCM and natural medicine widely and flexibly used in clinical practice, the efficacy, safety and mechanism of action need more in-depth experimental research.
引用
- Yang Z, Zhang Q, Yu L, et al. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer. J Ethnopharmacol. 2020. PMID: 32810619. doi:10.1016/j.jep.2020.113249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。